Please login to the form below

Not currently logged in
Email:
Password:

patient safety

This page shows the latest patient safety news and features for those working in and with pharma, biotech and healthcare.

bluebird bio to restart marketing of Zynteglo in EU after previous suspension

bluebird bio to restart marketing of Zynteglo in EU after previous suspension

EMA’s safety committee PRAC has confirmed favourable risk-benefit balance of gene therapy. ... Patient safety remains our top priority. To this end, we are grateful to the PRAC for its comprehensive review of the available evidence and positive

Latest news

More from news
Approximately 71 fully matching, plus 247 partially matching documents found.

Latest Intelligence

  • Recruiting patients for real-world studies – the power of a digital campaign Recruiting patients for real-world studies – the power of a digital campaign

    Research conducted outside randomised controlled trials (RCTs) can be used to monitor patient safety and measure drug utilisation. ... Will it be important, for example, to analyse the results by patient age and gender?

  • Empowering patients empowers results Empowering patients empowers results

    Patient-centricity is key when it comes to creating a more flexible, efficient and modern process for clinical trials. ... Decentralised clinical trials that can take place from a patient’s home are clearly gaining ground.

  • A cultural shift in clinical research A cultural shift in clinical research

    highest levels of patient safety. ... Similarly, telemedicine is now frequently used for routine patient monitoring and follow-ups, particularly in phase 1 studies.

  • AI and accelerated computing ring in new era for healthcare AI and accelerated computing ring in new era for healthcare

    As an added bonus, researchers can collaborate on AI model creation without sharing confidential patient information. ... These application frameworks facilitate a critically needed ecosystem of AI solutions for hospital public safety and patient

  • Rare genetic diseases – what’s in store for 2021? Rare genetic diseases – what’s in store for 2021?

    The healthcare industry will need to react and adapt to changes in safety and regulatory processes, patient access to medicines, access to research, clinical trial recruitment and the supply of medicines ... We’re looking at digital advances that would

More from intelligence
Approximately 1 fully matching, plus 42 partially matching documents found.

Latest appointments

More from appointments
Approximately 0 fully matching, plus 9 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 2 fully matching, plus 21 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Havas Lynx Group

We are the Havas Lynx Group. Devoted to fresh thinking. Changing the way the world does healthcare communications for the...

Latest intelligence

What does the future hold for Light-chain Amyloidosis?
Recent advances in the understanding and treatment are reforming pharma’s approach to the management of this rare disease. With a new standard of care rapidly developing, what does the landscape...
Webinar:
Securing a future for telehealth with immersive market research insights...
Accelerating patient recruitment in clinical trials with the Clinical Enrolment Managers (CEMs)
How Innovative Trials' global Clinical Enrolment Managers (CEMs) give clinical trial sites the local touch...